Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Completed Phase 2 Interventional

Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

ClinicalTrials.gov ID: NCT00006258

Public ClinicalTrials.gov record NCT00006258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 17, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Dose Intensive Chemotherapy for Patients Greater Than or Equal To 10 Years of Age With Newly Diagnosed High Stage Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors (PNET) and Ependymoma: A Feasibility Study of an Intensive Induction Chemotherapy Regimen Followed by Standard Irradiation

Study identification

NCT ID
NCT00006258
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Children's Hospital Los Angeles
Other
Enrollment
Not listed

Conditions and interventions

Interventions

  • adjuvant therapy Procedure
  • cisplatin Drug
  • cyclophosphamide Drug
  • etoposide Drug
  • filgrastim Biological
  • methotrexate Drug
  • radiation therapy Radiation
  • vincristine sulfate Drug

Procedure · Drug · Biological + 1 more

Eligibility (public fields only)

Age range
10 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 1997
Primary completion
Not listed
Completion
Dec 31, 2004
Last update posted
Jul 17, 2013

1997 – 2005

United States locations

U.S. sites
2
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027-0700 —
Geisinger Medical Center Danville Pennsylvania 17822-1320 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2013 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006258 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →